Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea | MicrobiomeTrials← Back to trialsNCT07600424
Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2027-12-31
Enrollment target: 10 participants Locations- Brigham and Women's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Facial Rosacea
This study aimed to evaluate the efficacy, tolerability, and safety of Eucerin Skin Relief Multi-Repair Cream containing…
Shanghai, ChinaEst. completion Jul 9, 2026
Rosacea
The skin and gut microbiome of rosacea patients differs from individuals without rosacea and that the microbiome suffers…
Baltimore, United StatesEst. completion Sep 2027
A Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea
Nanjing, ChinaCompleted Oct 30, 2026